Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-904
Closed -$140K 61
2023
Q4
$140K Sell
904
-614
-40% -$89.5K 0.11% 70
2023
Q3
$229K Buy
1,518
+522
+52% +$76.6K 0.2% 66
2023
Q2
$133K Buy
996
+158
+19% +$23.2K 0.11% 68
2023
Q1
$133K Buy
838
+359
+75% +$54.9K 0.11% 67
2022
Q4
$78K Buy
479
+94
+24% +$14.4K 0.07% 69
2022
Q3
$54K Hold
385
0.04% 76
2022
Q2
$59K Buy
+385
New +$58.8K 0.05% 73
2021
Q1
Sell
-30,090
Closed -$3.18M 315
2020
Q4
$3.18M Buy
30,090
+26,962
+862% +$2.59M 0.34% 85
2020
Q3
$273K Sell
3,128
-51,877
-94% -$4.88M 0.03% 253
2020
Q2
$5.35M Sell
55,005
-15,367
-22% -$1.35M 0.7% 36
2020
Q1
$5.33M Buy
70,372
+39,440
+128% +$3.36M 0.84% 29
2019
Q4
$2.74M Buy
30,932
+25,852
+509% +$2.15M 0.36% 77
2019
Q3
$380K Hold
5,080
0.05% 221
2019
Q2
$369K Hold
5,080
0.04% 243
2019
Q1
$407K Hold
5,080
0.05% 246
2018
Q4
$466K Sell
5,080
-22,648
-82% -$1.99M 0.06% 255
2018
Q3
$2.62M Sell
27,728
-97
-0.3% -$9.2K 0.29% 86
2018
Q2
$2.58M Buy
27,825
+23,545
+550% +$2.3M 0.33% 74
2018
Q1
$402K Sell
4,280
-16,744
-80% -$1.84M 0.05% 312
2017
Q4
$2.03M Buy
+21,024
New +$1.98M 0.26% 89

Other funds holding ABBV

Banco de Sabadell's ABBV Position: Q1 2024 in Review

Banco de Sabadell sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 904 shares — an estimated $140K sold.

Banco de Sabadell first reported a position in ABBV in Q4 2017 and held it in 20 quarters. The position peaked at $5.35M in Q2 2020. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Banco de Sabadell reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • Banco de Sabadell sold 904 AbbVie shares in Q1 2024, an estimated $140K.
  • Banco de Sabadell first reported a position in AbbVie in Q4 2017 and held it in 20 quarters.
  • Banco de Sabadell's AbbVie position peaked at $5.35M in Q2 2020.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Banco de Sabadell's 13F filing for Q1 2024, filed 14 May 2024.